SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001213900-15-003603
Filing Date
2015-05-13
Accepted
2015-05-13 17:26:55
Documents
18

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS f424a050715_biondvax.htm 424B4 4617177
2 GRAPHIC image002.jpg GRAPHIC 32407
3 GRAPHIC image003.jpg GRAPHIC 13486
4 GRAPHIC image004.jpg GRAPHIC 22776
5 GRAPHIC image005.jpg GRAPHIC 23260
6 GRAPHIC image006.jpg GRAPHIC 20666
7 GRAPHIC image007.jpg GRAPHIC 13869
8 GRAPHIC image008.jpg GRAPHIC 27847
9 GRAPHIC image009.jpg GRAPHIC 35708
10 GRAPHIC image010.jpg GRAPHIC 27035
11 GRAPHIC image011.jpg GRAPHIC 29608
12 GRAPHIC image012.jpg GRAPHIC 29200
13 GRAPHIC image013.jpg GRAPHIC 26977
14 GRAPHIC image014.jpg GRAPHIC 2270
15 GRAPHIC image015.jpg GRAPHIC 32409
16 GRAPHIC image016.jpg GRAPHIC 13487
17 GRAPHIC image017.jpg GRAPHIC 5895
18 GRAPHIC image_002.jpg GRAPHIC 4482
  Complete submission text file 0001213900-15-003603.txt   5118420
Mailing Address 14 EINSTEIN ST. NES-ZIONA L3 74036
Business Address 14 EINSTEIN ST. NES-ZIONA L3 74036 972-8-9302529
BiondVax Pharmaceuticals Ltd. (Filer) CIK: 0001611747 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1213
Type: 424B4 | Act: 33 | File No.: 333-201283 | Film No.: 15859435
SIC: 2836 Biological Products, (No Diagnostic Substances)